Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
Letter
Nature Medicine 12, 446 - 451 (2006)
Published online: 26 March 2006; | doi:10.1038/nm1388

Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells

Keisuke Ito, Atsushi Hirao, Fumio Arai, Keiyo Takubo, Sahoko Matsuoka, Kana Miyamoto, Masako Ohmura, Kazuhito Naka, Kentaro Hosokawa, Yasuo Ikeda & Toshio Suda

Supplementary Fig. 1 (pdf 4M)
Effect of increased ROS on HSCs and progenitor cells.

Supplementary Fig. 2 (pdf 2M)
Atm-/- HSCs are highly sensitive to ROS elevation in terms of p38 MAPK activation.

Supplementary Fig. 3 (pdf 5M)
Treatment with a p38 MAPK inhibitor rescues defective HSC function in Atm-/- mice.

Supplementary Fig. 4 (pdf 3M)
Elevation of ROS level and p16 Ink4a/p19 Arf expression in KSL cells during aging and serial transplantation.

Supplementary Fig. 5 (pdf 3M)
In vitro treatment with a p38 MAPK inhibitor restores BSO-induced defective repopulating capacity of HSCs.

Supplementary Table 1 (pdf 3M)
List of RT-PCR primers used in this study.


 Top
SUPPLEMENTARY INFO
Back to article
Table of contents
Download plugins

Open Innovation Challenges

naturejobs

natureproducts

Search buyers guide:

 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2006 Nature Publishing Group | Privacy policy